You are here: Industry Insights > A*STAR

News List

Waters Corp Expands Collaboration with BTI contractpharma
July 02, 2021
Waters Corporation is expanding its joint work with the Bioprocessing Technology Institute (BTI), a research institute of Singapore's Agency for Science, Technology and Research (A*STAR).
AVATAMED sets up Joint Service Lab with A*STAR's Institute of Molecular and Cell Biology to offer Precision Oncology Services prnasia
June 01, 2021
AVATAMED, a precision medicine service company based in Singapore, announced the setting up of a joint lab with Singapore's Institute of Molecular and Cell Biology (IMCB) at the Agency for Science, Technology and Research (A*STAR), to offer precision ...
Individual SARS-CoV-2 neutralising antibody immunity lasts from days to decades worldpharmanews
March 25, 2021
Scientists from Duke-NUS Medical School, the National Centre for Infectious Diseases (NCID) and the Agency for Science, Technology and Research (A*STAR) Infectious Diseases Labs found that antibodies against SARS-CoV-2 wane at different rates, lasting ...
Duke, GenScript, A*STAR Enter COVID-19 Pact contractpharma
May 19, 2020
Launch SARS-CoV-2 serology test to detect neutralizing antibodies without need of containment facility or specimen.
GE Healthcare, A*STAR co-develop innovative medical technologies biospectrumasia
May 07, 2018
The collaboration taps on Singapore’s strengths in research and development, and contributes to the growth of MedTech innovation in Asia and around the world.
A*STAR scientists’ discovery on Gastric Cancer pharmaasia
June 14, 2017
Scientists from A*STAR’s Institute of Medical Biology (IMB) have discovered gastric cancer is driven by Lgr5-expressing chief cells, a discovery that represents a significant breakthrough in the study of cancer biology...